• Info
  • Insider Ownership

Insider Trading & Ownership of A2A Pharmaceuticals, Inc.

Location
New York, NY
Summary
The estimated value of insider holdings of A2A Pharmaceuticals, Inc. is at least $13,238,750 dollars as of 02 Jun 2023. A2A Pharmaceuticals, Inc. is the 10%+ Owner of Biomea Fusion, Inc. and owns shares of Biomea Fusion, Inc. (BMEA) stock worth about $13.24M.
Signature
Edward Painter
All Insider Reports
All Insider Reports

Notify me when A2A Pharmaceuticals, Inc. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of A2A Pharmaceuticals, Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BMEA Biomea Fusion, Inc. 10%+ Owner $13,238,750 31 May 2023

Insider Transactions Reported by A2A Pharmaceuticals, Inc.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.